Cargando…

Comparison of botulinum toxin with surgery for the treatment of acute acquired comitant esotropia and its clinical characteristics

We compared the therapeutic effects between botulinum toxin and surgery for acute acquired comitant esotropia (AACE) and analyze its clinical characteristics. The data of the 29 cases, who received treatment for AACE in the Ophthalmic Center of the First Affiliated Hospital of Zhengzhou University a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, Li-juan, Zhu, Yu, Li, Zhi-gang, Zheng, Guang-ying, Peng, Hai-ying, Rong, Jun-bo, Xu, Li-min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761114/
https://www.ncbi.nlm.nih.gov/pubmed/31554874
http://dx.doi.org/10.1038/s41598-019-50383-x
_version_ 1783453956185260032
author Lang, Li-juan
Zhu, Yu
Li, Zhi-gang
Zheng, Guang-ying
Peng, Hai-ying
Rong, Jun-bo
Xu, Li-min
author_facet Lang, Li-juan
Zhu, Yu
Li, Zhi-gang
Zheng, Guang-ying
Peng, Hai-ying
Rong, Jun-bo
Xu, Li-min
author_sort Lang, Li-juan
collection PubMed
description We compared the therapeutic effects between botulinum toxin and surgery for acute acquired comitant esotropia (AACE) and analyze its clinical characteristics. The data of the 29 cases, who received treatment for AACE in the Ophthalmic Center of the First Affiliated Hospital of Zhengzhou University and Henan Provincial Ophthalmology Hospital between January 2016 and January 2017, were collected. The 29 cases with AACE were followed for 6 months or more, and received either botulinum toxin injection (group A with 13 cases) or squint correction (group B with 16 cases). The distant and near deviation angles were compared between the two groups before and after treatment. The success rate (total horizontal deviation of 10 prism diopters or less) and stereopsis were compared between the two groups at post-treatment 6 months. At the same time, the relations between distant and near deviation angles were analyzed among different myopia levels and different AACE types. Results indicated that he success rate was not significantly different at post-treatment 6 months (84.6% vs 81.3%, P = 1.00). The distant and near deviation angles were all significantly different one day and one month after treatment (all P < 0.05); but at post-treatment 6 months, they were not significantly different (all P > 0.05) between the two groups. There were no significant differences in the distant and near stereoacuity between the two groups at post-treatment 6 months (all P > 0.05). Among the 25 cases with myopia, the pre-treatment distant deviation angle was significantly higher than pre-treatment near deviation angle in the cases with myopia level >−2.5 D (P < 0.05), and the pre-treatment distant and near deviation angles were all significantly higher in the cases with type-IIAACE than in the cases with type-IIIAACE (all P < 0.05). This study suggests that Botulinum toxin is as effective as surgery in the treatment of AACE at post-treatment 6 months. For the cases with myopia level >−2.5 D, the pre-treatment distant deviation angle is significantly higher than pre-treatment near deviation angle; and both pre-treatment distant and near deviation angles are greater in the cases with type-IIAACE than in the cases with type-IIIAACE.
format Online
Article
Text
id pubmed-6761114
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-67611142019-11-12 Comparison of botulinum toxin with surgery for the treatment of acute acquired comitant esotropia and its clinical characteristics Lang, Li-juan Zhu, Yu Li, Zhi-gang Zheng, Guang-ying Peng, Hai-ying Rong, Jun-bo Xu, Li-min Sci Rep Article We compared the therapeutic effects between botulinum toxin and surgery for acute acquired comitant esotropia (AACE) and analyze its clinical characteristics. The data of the 29 cases, who received treatment for AACE in the Ophthalmic Center of the First Affiliated Hospital of Zhengzhou University and Henan Provincial Ophthalmology Hospital between January 2016 and January 2017, were collected. The 29 cases with AACE were followed for 6 months or more, and received either botulinum toxin injection (group A with 13 cases) or squint correction (group B with 16 cases). The distant and near deviation angles were compared between the two groups before and after treatment. The success rate (total horizontal deviation of 10 prism diopters or less) and stereopsis were compared between the two groups at post-treatment 6 months. At the same time, the relations between distant and near deviation angles were analyzed among different myopia levels and different AACE types. Results indicated that he success rate was not significantly different at post-treatment 6 months (84.6% vs 81.3%, P = 1.00). The distant and near deviation angles were all significantly different one day and one month after treatment (all P < 0.05); but at post-treatment 6 months, they were not significantly different (all P > 0.05) between the two groups. There were no significant differences in the distant and near stereoacuity between the two groups at post-treatment 6 months (all P > 0.05). Among the 25 cases with myopia, the pre-treatment distant deviation angle was significantly higher than pre-treatment near deviation angle in the cases with myopia level >−2.5 D (P < 0.05), and the pre-treatment distant and near deviation angles were all significantly higher in the cases with type-IIAACE than in the cases with type-IIIAACE (all P < 0.05). This study suggests that Botulinum toxin is as effective as surgery in the treatment of AACE at post-treatment 6 months. For the cases with myopia level >−2.5 D, the pre-treatment distant deviation angle is significantly higher than pre-treatment near deviation angle; and both pre-treatment distant and near deviation angles are greater in the cases with type-IIAACE than in the cases with type-IIIAACE. Nature Publishing Group UK 2019-09-25 /pmc/articles/PMC6761114/ /pubmed/31554874 http://dx.doi.org/10.1038/s41598-019-50383-x Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Lang, Li-juan
Zhu, Yu
Li, Zhi-gang
Zheng, Guang-ying
Peng, Hai-ying
Rong, Jun-bo
Xu, Li-min
Comparison of botulinum toxin with surgery for the treatment of acute acquired comitant esotropia and its clinical characteristics
title Comparison of botulinum toxin with surgery for the treatment of acute acquired comitant esotropia and its clinical characteristics
title_full Comparison of botulinum toxin with surgery for the treatment of acute acquired comitant esotropia and its clinical characteristics
title_fullStr Comparison of botulinum toxin with surgery for the treatment of acute acquired comitant esotropia and its clinical characteristics
title_full_unstemmed Comparison of botulinum toxin with surgery for the treatment of acute acquired comitant esotropia and its clinical characteristics
title_short Comparison of botulinum toxin with surgery for the treatment of acute acquired comitant esotropia and its clinical characteristics
title_sort comparison of botulinum toxin with surgery for the treatment of acute acquired comitant esotropia and its clinical characteristics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761114/
https://www.ncbi.nlm.nih.gov/pubmed/31554874
http://dx.doi.org/10.1038/s41598-019-50383-x
work_keys_str_mv AT langlijuan comparisonofbotulinumtoxinwithsurgeryforthetreatmentofacuteacquiredcomitantesotropiaanditsclinicalcharacteristics
AT zhuyu comparisonofbotulinumtoxinwithsurgeryforthetreatmentofacuteacquiredcomitantesotropiaanditsclinicalcharacteristics
AT lizhigang comparisonofbotulinumtoxinwithsurgeryforthetreatmentofacuteacquiredcomitantesotropiaanditsclinicalcharacteristics
AT zhengguangying comparisonofbotulinumtoxinwithsurgeryforthetreatmentofacuteacquiredcomitantesotropiaanditsclinicalcharacteristics
AT penghaiying comparisonofbotulinumtoxinwithsurgeryforthetreatmentofacuteacquiredcomitantesotropiaanditsclinicalcharacteristics
AT rongjunbo comparisonofbotulinumtoxinwithsurgeryforthetreatmentofacuteacquiredcomitantesotropiaanditsclinicalcharacteristics
AT xulimin comparisonofbotulinumtoxinwithsurgeryforthetreatmentofacuteacquiredcomitantesotropiaanditsclinicalcharacteristics